<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37522958</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-160X</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Rheumatology international</Title><ISOAbbreviation>Rheumatol Int</ISOAbbreviation></Journal><ArticleTitle>Diagnostic challenge of tuberculosis in systemic lupus erythematosus: a case report and literature review.</ArticleTitle><Pagination><StartPage>2131</StartPage><EndPage>2139</EndPage><MedlinePgn>2131-2139</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00296-023-05400-8</ELocationID><Abstract><AbstractText>Patients with systemic lupus erythematosus (SLE) are at increased risk of tuberculosis (TB) infection due to immune dysfunction and immunosuppressive therapy. We present a case study of a 40-year-old woman with systemic lupus erythematosus (SLE). Initially, she was diagnosed with a lupus flare based on her clinical symptoms and laboratory results. However, upon further investigation, positive polymerase-chain reaction results for M. tuberculosis in the cerebrospinal fluid and lung parenchymal changes on chest computed tomography scan were indicative of TB infection. There was initial uncertainty regarding whether TB had triggered a flare-up of SLE or if TB was merely mimicking the symptoms of a SLE flare-up. However, as increasing the prednisolone dose did not have a positive effect and the patient's condition improved significantly with anti-TB treatment alone, it became clearer that the deterioration observed upon admission was primarily due to TB progression rather than an SLE flare-up. Additionally, we review the current literature on TB and SLE, including risk factors, diagnostic challenges, and treatment considerations, highlighting the importance of considering TB infection in patients with SLE who present with overlapping manifestations. Prompt diagnosis and treatment are essential for improving outcomes in these patients.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smiyan</LastName><ForeName>Svitlana</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5543-9895</Identifier><AffiliationInfo><Affiliation>2nd Department of Internal Medicine, Ivan Horbachevsky Ternopil National Medical University, Majdan Voli, 1, Ternopil, 46001, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koshak</LastName><ForeName>Bohdan</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-8470-4421</Identifier><AffiliationInfo><Affiliation>2nd Department of Internal Medicine, Ivan Horbachevsky Ternopil National Medical University, Majdan Voli, 1, Ternopil, 46001, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komorovsky</LastName><ForeName>Roman</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-0288-4132</Identifier><AffiliationInfo><Affiliation>2nd Department of Internal Medicine, Ivan Horbachevsky Ternopil National Medical University, Majdan Voli, 1, Ternopil, 46001, Ukraine. komorovsky@tdmu.edu.ua.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slaba</LastName><ForeName>Ulyana</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0002-2279-2403</Identifier><AffiliationInfo><Affiliation>2nd Department of Internal Medicine, Ivan Horbachevsky Ternopil National Medical University, Majdan Voli, 1, Ternopil, 46001, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilukha</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4116-8611</Identifier><AffiliationInfo><Affiliation>2nd Department of Internal Medicine, Ivan Horbachevsky Ternopil National Medical University, Majdan Voli, 1, Ternopil, 46001, Ukraine.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Rheumatol Int</MedlineTA><NlmUniqueID>8206885</NlmUniqueID><ISSNLinking>0172-8172</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9PHQ9Y1OLM</RegistryNumber><NameOfSubstance UI="D011239">Prednisolone</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067251" MajorTopicYN="N">Symptom Flare Up</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014376" MajorTopicYN="Y">Tuberculosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011239" MajorTopicYN="N">Prednisolone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005938" MajorTopicYN="N">Glucocorticoids</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009169" MajorTopicYN="Y">Mycobacterium tuberculosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Immunosuppressive therapy</Keyword><Keyword MajorTopicYN="N">Meningitis</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">Tuberculosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>11</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37522958</ArticleId><ArticleId IdType="doi">10.1007/s00296-023-05400-8</ArticleId><ArticleId IdType="pii">10.1007/s00296-023-05400-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ameer MA, Chaudhry H, Mushtaq J, Khan OS, Babar M, Hashim T, Zeb S, Tariq MA, Patlolla SR, Ali J, Hashim SN, Hashim S (2022) An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management. Cureus 14:e30330. https://doi.org/10.7759/cureus.30330</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.30330</ArticleId><ArticleId IdType="pubmed">36407159</ArticleId><ArticleId IdType="pmc">9662848</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley ITW, Sawalha AH (2022) Systemic lupus erythematosus as a genetic disease. Clin Immunol 236:108953. https://doi.org/10.1016/j.clim.2022.108953</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2022.108953</ArticleId><ArticleId IdType="pubmed">35149194</ArticleId><ArticleId IdType="pmc">9167620</ArticleId></ArticleIdList></Reference><Reference><Citation>Fava A, Petri M (2019) Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun 96:1&#x2013;13. https://doi.org/10.1016/j.jaut.2018.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.11.001</ArticleId><ArticleId IdType="pubmed">30448290</ArticleId></ArticleIdList></Reference><Reference><Citation>Gergianaki I, Garantziotis P, Adamichou C, Saridakis I, Spyrou G, Sidiropoulos P, Bertsias G (2021) High comorbidity burden in patients with SLE: data from the community-based lupus registry of Crete. J Clin Med 10:998. https://doi.org/10.3390/jcm10050998</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10050998</ArticleId><ArticleId IdType="pubmed">33801229</ArticleId><ArticleId IdType="pmc">7957898</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello N, Meyers KJ, Workman J, Hartley L, McMahon M (2023) Cardiovascular events and risk in patients with systemic lupus erythematosus: systematic literature review and meta-analysis. Lupus 32:325&#x2013;341. https://doi.org/10.1177/09612033221147471</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033221147471</ArticleId><ArticleId IdType="pubmed">36547368</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Liu Y, Wang W, Zhang Y, Liu K, Chen SH, Chen B (2022) Incidence and prevalence of tuberculosis in systemic lupus erythematosus patients: a systematic review and meta-analysis. Front Immunol 13:938406. https://doi.org/10.3389/fimmu.2022.938406</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.938406</ArticleId><ArticleId IdType="pubmed">35935948</ArticleId><ArticleId IdType="pmc">9355093</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu CY, Kuo CF, Chou IJ, Chen JS, Lu HY, Wu CY, Chen LC, Huang JL, Yeh KW (2022) Comorbidities of systemic lupus erythematosus prior to and following diagnosis in different age-at-onset groups. Lupus 31:963&#x2013;973. https://doi.org/10.1177/09612033221100908</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033221100908</ArticleId><ArticleId IdType="pubmed">35536913</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Gonz&#xe1;lez P, Romero-D&#xed;az J, Cervera-Hern&#xe1;ndez ME, Ocampo-Torres M, Chaires-Garza LG, Lastiri-Gonz&#xe1;lez EA, Atisha-Fregoso Y, Bobadilla-Del-Valle M, Ponce-de-Le&#xf3;n A, Sifuentes-Osornio J (2018) Tuberculosis and systemic lupus erythematosus: a case-control study in Mexico City. Clin Rheumatol 37:2095&#x2013;2102. https://doi.org/10.1007/s10067-018-4109-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-018-4109-z</ArticleId><ArticleId IdType="pubmed">29675624</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuchacovich R, Gedalia A (2009) Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus. Rheum Dis Clin N Am 35:75&#x2013;93. https://doi.org/10.1016/j.rdc.2009.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rdc.2009.03.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamijoyo L, Sahiratmadja E, Ghassani NG, Darmawan G, Susandi E, van Crevel R, Hill PC, Alisjahbana B (2022) Tuberculosis among patients with systemic lupus erythematosus in Indonesia: a cohort study. Open Forum Infect Dis 9:ofac201. https://doi.org/10.1093/ofid/ofac201</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac201</ArticleId><ArticleId IdType="pubmed">35794932</ArticleId><ArticleId IdType="pmc">9251660</ArticleId></ArticleIdList></Reference><Reference><Citation>Damara I, Ariane A, Winston K (2022) Predisposing factors of tuberculosis infection in systemic lupus erythematosus patients: a single-center case-control study. Cureus 14:e26410. https://doi.org/10.7759/cureus.26410</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.26410</ArticleId><ArticleId IdType="pubmed">35915698</ArticleId><ArticleId IdType="pmc">9337775</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok MY, Wong SS, Chan TM, Fong DY, Wong WS, Lau CS (2007) Nontuberculous mycobacterial infection in patients with systemic lupus erythematosus. Rheumatology 46:280&#x2013;284. https://doi.org/10.1093/rheumatology/kel206</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kel206</ArticleId><ArticleId IdType="pubmed">16861709</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin JI, Lee KH, Park S, Yang JW, Kim HJ, Song K, Lee S, Na H, Jang YJ, Nam JY, Kim S, Lee C, Hong C, Kim C, Kim M, Choi U, Seo J, Jin H, Yi B, Jeong SJ, Sheok YO, Kim H, Lee S, Lee S, Jeong YS, Park SJ, Kim JH, Kronbichler A (2022) Systemic lupus erythematosus and lung involvement: a comprehensive review. J Clin Med 11:6714. https://doi.org/10.3390/jcm11226714</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11226714</ArticleId><ArticleId IdType="pubmed">36431192</ArticleId><ArticleId IdType="pmc">9698564</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader KH, Daikh DI, Brinks R, Mosca M, Ramsey-Goldman R et al (2019) 2019 EULAR/ACR classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 71:1400&#x2013;1412. https://doi.org/10.1002/art.40930</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40930</ArticleId><ArticleId IdType="pubmed">31385462</ArticleId><ArticleId IdType="pmc">6827566</ArticleId></ArticleIdList></Reference><Reference><Citation>Enocsson H, Karlsson J, Li HY, Wu Y, Kushner I, Wetter&#xf6; J, Sj&#xf6;wall C (2021) The complex role of C-reactive protein in systemic lupus erythematosus. J Clin Med 10:5837. https://doi.org/10.3390/jcm10245837</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245837</ArticleId><ArticleId IdType="pubmed">34945133</ArticleId><ArticleId IdType="pmc">8708507</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Che G, Liu Y, Xu K (2023) Tuberculosis mimicking the onset of systemic lupus erythematosus flare: case based review. Int J Rheum Dis 26:1143&#x2013;1148. https://doi.org/10.1111/1756-185X.14585</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.14585</ArticleId><ArticleId IdType="pubmed">36724496</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, Svenungsson E, Peterson J, Clarke AE, Ramsey-Goldman R (2021) Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol 17:515&#x2013;532. https://doi.org/10.1038/s41584-021-00668-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00668-1</ArticleId><ArticleId IdType="pubmed">34345022</ArticleId><ArticleId IdType="pmc">8982275</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang G, Chen X, Han Y, Peng Q, Liu J, Liu Y, Guo H, Wu X, Liu J, Zhou Q, Long L (2023) Clinical characteristics and related influencing factors of common rheumatic diseases concomitant with tuberculosis. Front Public Health 10:948652. https://doi.org/10.3389/fpubh.2022.948652</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.948652</ArticleId><ArticleId IdType="pubmed">36726623</ArticleId><ArticleId IdType="pmc">9884836</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, Houssiau F, Jayne D, Kouloumas M, Kuhn A, Larsen JL, Lerstr&#xf8;m K, Moroni G, Mosca M, Schneider M, Smolen JS, Svenungsson E, Tesar V, Tincani A, Troldborg A, van Vollenhoven R, Wenzel J, Bertsias G, Boumpas DT (2019) 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 78:736&#x2013;745. https://doi.org/10.1136/annrheumdis-2019-215089</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-215089</ArticleId><ArticleId IdType="pubmed">30926722</ArticleId></ArticleIdList></Reference><Reference><Citation>Balbi GGM, Machado-Ribeiro F, Marques CDL, Signorelli F, Levy RA (2018) The interplay between tuberculosis and systemic lupus erythematosus. Curr Opin Rheumatol 30:395&#x2013;402. https://doi.org/10.1097/BOR.0000000000000493</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000493</ArticleId><ArticleId IdType="pubmed">29438163</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang H, Lan L, Qu Y, Zhang Q, Lv J (2018) Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus. J Int Med Res 46:485&#x2013;491. https://doi.org/10.1177/0300060517722695</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060517722695</ArticleId><ArticleId IdType="pubmed">28823196</ArticleId></ArticleIdList></Reference><Reference><Citation>Miras MDMA, Hidalgo-Tenorio C, Jimenez-Gamiz P, Jimenez-Alonso J (2014) Diagnosis of latent tuberculosis in patients with systemic lupus erythematosus: T.SPOT.TB versus tuberculin skin test. Biomed Res Int 2014:291031. https://doi.org/10.1155/2014/291031</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/291031</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadavath S, Zapantis E, Henriquez W, Mehta B, Efthimiou P (2014) Effectiveness of combining tuberculin skin test and interferon gamma release assays as a screening strategy for detecting latent tuberculosis infection in high-risk patients with systemic lupus erythematosus. Ann Rheum Dis 72(Suppl 3):A478. https://doi.org/10.1136/annrheumdis-2013-eular.1435</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-eular.1435</ArticleId></ArticleIdList></Reference><Reference><Citation>Acharya B, Acharya A, Gautam S, Ghimire SP, Mishra G, Parajuli N, Sapkota B (2020) Advances in diagnosis of tuberculosis: an update into molecular diagnosis of Mycobacterium tuberculosis. Mol Biol Rep 47:4065&#x2013;4075. https://doi.org/10.1007/s11033-020-05413-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-020-05413-7</ArticleId><ArticleId IdType="pubmed">32248381</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamada Y, Cirillo DM, Matteelli A, Penn-Nicholson A, Rangaka MX, Ruhwald M (2021) Tests for tuberculosis infection: landscape analysis. Eur Respir J 58:2100167. https://doi.org/10.1183/13993003.00167-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00167-2021</ArticleId><ArticleId IdType="pubmed">33875495</ArticleId></ArticleIdList></Reference><Reference><Citation>Furin J, Cox H, Pai M (2019) Tuberculosis. Lancet 393:1642&#x2013;1656. https://doi.org/10.1016/S0140-6736(19)30308-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)30308-3</ArticleId><ArticleId IdType="pubmed">30904262</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello N, Birt JA, Workman J, Zhou X, Ross-Terres JA, Petri M (2022) Treatment patterns and clinical characteristics of patients with systemic lupus erythematosus and musculoskeletal symptoms: a retrospective, observational study. Adv Ther 39:3131&#x2013;3145. https://doi.org/10.1007/s12325-022-02148-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-022-02148-8</ArticleId><ArticleId IdType="pubmed">35534786</ArticleId><ArticleId IdType="pmc">9239948</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Balushi F, Al Salmi I, Metry AM, Yousef MA, Hannawi S (2018) Clinical pharmacological management status of systemic lupus erythematous population: situational analysis. J Rheum Dis Treat 4:068. https://doi.org/10.23937/2469-5726/1510068</Citation><ArticleIdList><ArticleId IdType="doi">10.23937/2469-5726/1510068</ArticleId></ArticleIdList></Reference><Reference><Citation>Fragoulis GE, Nikiphorou E, Dey M, Zhao SS, Courvoisier DS, Arnaud L et al (2023) 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 82:742&#x2013;753. https://doi.org/10.1136/ard-2022-223335</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard-2022-223335</ArticleId><ArticleId IdType="pubmed">36328476</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xf6;rner T, Furie R (2019) Novel paradigms in systemic lupus erythematosus. Lancet 393:2344&#x2013;2358. https://doi.org/10.1016/S0140-6736(19)30546-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)30546-X</ArticleId><ArticleId IdType="pubmed">31180031</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Arbi KMS, Magula NP, Mody GM (2023) Tuberculosis remains a major burden in systemic lupus erythematosus patients in Durban, South Africa. Front Med (Lausanne) 10:1118390. https://doi.org/10.3389/fmed.2023.1118390</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1118390</ArticleId><ArticleId IdType="pubmed">36936236</ArticleId></ArticleIdList></Reference><Reference><Citation>MacGregor-Fairlie M, Wilkinson S, Besra GS, Goldberg Oppenheimer P (2020) Tuberculosis diagnostics: overcoming ancient challenges with modern solutions. Emerg Top Life Sci 4:423&#x2013;436. https://doi.org/10.1042/ETLS20200335</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/ETLS20200335</ArticleId><ArticleId IdType="pubmed">33258943</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal H, Screws B, Khan MS (2023) A case of previously undiagnosed systemic lupus erythematosus and mycobacterium tuberculosis infection presenting as diffuse alveolar hemorrhage. Case Rep Rheumatol 2023:3686772. https://doi.org/10.1155/2023/3686772</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/3686772</ArticleId><ArticleId IdType="pubmed">36686202</ArticleId><ArticleId IdType="pmc">9848806</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>